Stock listing

FAGR Stock Price, News, Filings & Events — Fagron Sa

Selected listing: FAGR · EURONEXT · EUR · BE

This page tracks Fagron Sa's FAGR:EURONEXT listing on EURONEXT in EUR for BE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following FAGR:EURONEXT. FAGR:EURONEXT is the stock-level entry point for investors researching Fagron Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Fagron SA is a public company listed on the Belgium market under the ticker FAGR. With a market capitalization of approximately €1.94 billion, Fagron specializes in pharmaceutical compounding and offers customized medication solutions. The company focuses on innovation and quality to meet the needs of healthcare professionals and patients.

FAGR:EURONEXTEURBEUpdated August 22, 2026
Fagron Sa logo
Ticker
FAGR:EURONEXT
Asset type
Stock
Market cap
$1.92B
Sector
Distribution Services
Industry
Medical Distributors
Exchange
EURONEXT
Currency
EUR

Fagron Sa FAGR:EURONEXT stock context

This page tracks Fagron Sa's FAGR:EURONEXT listing on EURONEXT in EUR for BE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following FAGR:EURONEXT. FAGR:EURONEXT is the stock-level entry point for investors researching Fagron Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Fagron SA is a public company listed on the Belgium market under the ticker FAGR. With a market capitalization of approximately €1.94 billion, Fagron specializes in pharmaceutical compounding and offers customized medication solutions. The company focuses on innovation and quality to meet the needs of healthcare professionals and patients.

Latest news from Fagron Sa

All Fagron Sa news →

Fagron Sa earnings calls

Research Fagron Sa

Alternate listings